iHeart Japan
ActiveiHeart Japan is developing regenerative medicinal products for severe heart failure, using iPSC technologies.
What it does
iHeart Japan Corporation is developing regenerative medicinal products for severe heart failure, using iPSC technologies. Its base technologies were invented by scientists of Kyoto University.
Its site says now · captured 2026-08-23
iHeart Japan株式会社
iHeart Japan株式会社は、多くの命を救うことを志して、iPS細胞を使った再生医療製品を開発しています。
Next to it in Healthcare and bio · iPSC regenerative medicine for heart failure
- Cell Factor Inc.Plug and Play
Renewal medicine 3 elements +1 authentic society implementation -from postcolona, from intractable diseases to pre -empty medical care. / 再生医療3要素 +1の本格社会実装 ～ポストコロナ、難病から先制医療まで～
- 株式会社メトセラPlug and Play
Metcela is a clinical-stage biotech startup providing patients with an alternative treatment option for heart disease.
- マイキャン・テクノロジーズ株式会社Plug and Play
MiCAN Technologies medical and nursing Care company.
- 株式会社幹細胞&デバイス研究所Plug and Play
Stem Cell & Device Laboratory is aiming to contribute to a healthy society with new cell application products.
- A-wavePlug and Play
Research and development of a wearable device, AI, and application for monitoring the exacerbation of heart failure at home. Provide a wristwatch-type wearable device that detects symptoms related to heart failure.
- 株式会社セルージョンPlug and Play
Cellusion is a developer of corneal endothelial regenerative medicine intended to improve world visibility.
- 株式会社ヘリオスPlug and Play
Healios develops treatments for retinal diseases and age-related macular degeneration (AMD) using cell technology.
- 株式会社マトリクソームPlug and Play
Matricome develops regenerative medicines by disseminating laminin E8 fragment technology.